Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-02-11

FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved the original application for a generic Triamterene and Hydrochlorothiazide tablet from Zydus Lifesciences Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triamterene and Hydrochlorothiazide (Triamterene and hydrochlorothiazide)

Snippet

ORIG AP for TRIAMTERENE AND HYDROCHLOROTHIAZIDE (TRIAMTERENE AND HYDROCHLOROTHIAZIDE)